Skip to main content
. Author manuscript; available in PMC: 2025 Feb 17.
Published in final edited form as: Ann Surg Oncol. 2014 Dec 18;22(7):2416–2423. doi: 10.1245/s10434-014-4285-2

Table 3.

Relationship of BMI category and sarcopenia status with resection

Resection
Patient Characteristic n (%) n (%) P-Value

All Patients 89 (100%) 57 (64%)
Pretreatment BMI 0.30
Normal/Underweight 37 (41%) 26 (70%)
Overweight/Obese 52 (58%) 31 (60%)

Pretreatment Sarcopenia* 0.79
No 38 (45%) 25 (66%)
Yes 46 (55%) 29 (63%)

Pretreatment Sarcopenia and Overweight/Obese 0.07
No 66 (76%) 46 (70%)
Yes 21 (24%) 10 (48%)

Post-treatment Sarcopenia 0.53
No 35 (41%) 21 (60%)
Yes 51 (59%) 34 (67%)

Weight Loss 0.42
No 33 (38%) 23 (70%)
Yes 54 (62%) 33 (61%)

Pre/Post-treatment Sarcopenia 0.50
No/No 30 (37%) 18 (60%)
No/Yes 8 (10%) 7 (88%)
Yes/No 4 (5%) 3 (75%)
Yes/Yes 40 (49%) 25 (63%)
*

Defined as L3 skeletal muscle cross-sectional area ≤38.9 cm2/m2 for women and ≤55.4 cm2/m2 for men. Sufficient information is available for 84 of the 89 patients for pretreatment sarcopenia determination.